SHENZHEN, China, Nov. 22, 2023 /PRNewswire/ — Today, XtalPi announced that it has signed a Memorandum of Understanding (MOU) with the Experimental Drug Development Centre (EDDC), Singapore’s national drug discovery and development platform hosted by A*STAR, for the expansion of their collaboration to encompass potential projects that will focus on the application of automated synthesis solutions and large language models in pharmaceutical research. Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targeted therapies for non-small cell lung cancer, the new collaboration aims to expedite the conversion of scientific…